This review discusses the evidence in support of the use of fluticasone propionate and eforomoterol fumarate dihydrate metered-dose inhaler [Flutiform®] for the treatment of asthma.
Independent expert commentary provided by Associate Professor Greg King.
Please login below to download this issue (PDF)